TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
MAJOR CONTRIBUTORS
Athletes and their physicians seeking Therapeutic Use Exemption (TUE) for the use of prohibited substances deserve the best advice available.
The WADA TUE Expert Group thanks clinicians for their contribution to the development of the WADA Medical Information to Support the Decisions of TUE Committees. Their collaboration has enabled WADA TUE Working Group members to provide an expert contemporary opinion for which they are most grateful.
Adrenal Insufficiency
Professor Martine Duclos Department of Sports Medicine and Functional Explorations CHU G. Montpied Clermont-Ferrand France
Dr. Katharina Grimm Member, CAF TUE Advisory Group Chair, FIMS Interfederal Commission Director of Medical Affairs, Aspetar Orthopaedic and Sports Medicine Hospital Qatar
Dr. Holger S. Willenberg Department of Endocrinology, Diabetes and Rheumatology University Hospital Düsseldorf Düsseldorf Germany
Anaphylaxis
Professor Ken Fitch, M.D. School of Sport Science, Exercise and Health Faculty of Life Science University of Western Australia Australia
© WADA - World Anti-Doping Program 1 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Dr. Margo Mountjoy, M.D., CCFP, FCFP, FACSM, Dip Sport Med FINA Bureau Sports Medicine Liaison IOC Medical Commission – Games Group McMaster University Medical School, Department of Family Medicine Rockwood, Ontario Canada
Professor F. Estelle Simons Department of Pediatrics & Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba Winnipeg, Manitoba Canada
Androgen Deficiency / Male Hypogonadism
Dr. Richard V. Clark, M.D., Ph.D., FACP Group Director, Discovery Medicine Muscle Metabolism DPU, Metabolic Pathways-Cardiovascular Therapeutic Unit GlaxoSmithKline R & D United States of America
Dr. David Handelsman ANZAC Research Institute University of Sydney Department of Andrology, Concord Hospital Sydney Australia
Dr. Robert W. Hudson M.D., Ph.D., FRCPC Professor and Chair, Division of Endocrinology and Metabolism, Department of Medicine, Queen's University and Kingston General and Hotel Dieu Hospitals Kingston, Ontario Canada
Dr. John Lombardo Medical Director, MAX Sports Medicine Institute Ohio Health United States of America
Dr. Gordon Matheson Professor, Department of Orthopedic Surgery, Stanford University School of Medicine Director of Sports Medicine, Head Team Physician, Stanford University Department of Athletics United States of America
© WADA - World Anti-Doping Program 2 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Dr. Alvin M. Matsumoto, M.D. Professor, Department of Medicine Division of Gerontology & Geriatric Medicine University of Washington School of Medicine Associate Director, Geriatric Research, Education and Clinical Center Director, Clinical Research Unit Seattle, WA United States of America
Professor Robert McLachlan, M.D., Ph.D. Director, Andrology Australia Director of Clinical Research Prince Henry's Institute of Medical Research Clayton Australia
Professor Dr. Med. Dr. h. c. Eberhard Nieschlag, FRCP Centre for Reproductive Medicine and Andrology of the University WHO Collaboration Centre for Research in Male Reproduction Münster Germany
Dr. Ronald S. Swerdloff, M.D. Professor of Medicine David Geffen School of Medicine at UCLA Chief Division of Endocrinology Harbor UCLA Medical Center Torrance, CA United States of America
Dr. Frederick CW Wu Professor of Medicine and Endocrinology Andrology Research Unit Department of Medicine University of Manchester Manchester United Kingdom
Arterial Hypertension
Professor Antonio Pelliccia Scientific Director Institute of Sports Medicine and Science Italian National Olympic Committee Italia
© WADA - World Anti-Doping Program 3 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Dr. Anik Sax Chief Physician, Medical and Sports Department Ministère de l'Éducation Nationale, de la Formation Professionnelle et des Sports Luxembourg
Professor Rob Walker Dunedin School of Medicine University of Otago New Zealand
Asthma
Professor Louis-Phillipe Boulet Université Laval Sainte-Foy, Quebec Canada
Professor Joe Cummiskey, M.D. Dublin Ireland
Professor Ken Fitch, M.D. School of Sport Science, Exercise and Health Faculty of Life Science University of Western Australia Australia
Professor Don McKenzie Allan McGavin Sports Medicine Centre University of British Columbia Vancouver, British Columbia Canada
Dr. Margo Mountjoy, M.D., CCFP, FCFP, FACSM, Dip Sport Med FINA Bureau Sports Medicine Liaison IOC Medical Commission – Games Group McMaster University Medical School, Department of Family Medicine, Rockwood, Ontario Canada
© WADA - World Anti-Doping Program 4 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Attention Deficit Hyperactivity Disorder (ADHD) in children and young adults
Dr. Lily Hechtman, M.D. F.R.C.P. Professor of Psychiatry and Pediatrics Director of Research, Division of Child Psychiatry, McGill University Montreal Children’s Hospital Montreal, Quebec Canada
Dr. William Mahoney, M.D., FRCPC Developmental Pediatrician, Clinical Associate Professor Department of Pediatrics, Faculty of Health Sciences, McMaster University Canada
Dr. Saul Marks, BScH, M.D., FRCPC, Honorary Secretary, FINA Sports Medicine Committee Executive Board, International Society for Sport Psychiatry North York General Hospital, Lecturer, Health and Disease Department of Psychiatry, University of Toronto Canada
Dr. Margo Mountjoy, M.D., CCFP, FCFP, FACSM, Dip Sport Med FINA Bureau Sports Medicine Liaison IOC Medical Commission – Games Group McMaster University Medical School, Department of Family Medicine, Rockwood, Ontario Canada
Diabetes Mellitus
Professor Heather Dean, M.D., FRCPC Assistant Dean (academic), Faculty of Medicine Professor, Department of Pediatrics, Section of Pediatric Endocrinology University of Manitoba Winnipeg, Manitoba, Canada
Dr. Katharina Grimm Member, CAF TUE Advisory Group Chair, FIMS Interfederal Commission Director of Medical Affairs, Aspetar Orthopaedic and Sports Medicine Hospital Qatar
Dr. Sandra Hoffmann, M.D. Associate Clinical Professor and Team Physician Idaho State University United States of America
© WADA - World Anti-Doping Program 5 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Professor Fuminori Katsukawa M.D., Ph.D. Professor, Sports Medicine Research Center, Keio University Yokohama Japan
Professor Patrick Manning, M.D. Department of Medicine University of Otago - Dunedin School of Medicine New Zealand
Professor Ayesha Motala Department of Diabetes and Endocrinology School of Clinical Medicine, Faculty of Health Sciences, Nelson R. Mandela School of Medicine University of KwaZulu-Natal Durban South Africa
Dr. Jake K Powrie, M.D., FRCP Consultant and Honorary Senior Lecturer and Clinical Lead in Diabetes and Endocrinology Guy's Hospital London United Kingdom
Female-to-Male (FtM) Transsexual Athletes
Dr. Alessandra D. Fisher, M.D. Endocrinologist Department of Clinical Physiopathology, Sexual Medicine and Andrology Unit, Interdepartmental Center for GID Assistance, University of Florence Italy
Professor Louis Gooren Emeritus Professor of Endocrinology VU University of Amsterdam Amsterdam The Netherlands
Dr. Katharina Grimm Member, CAF TUE Advisory Group Chair, FIMS Interfederal Commission Director of Medical Affairs, Aspetar Orthopaedic and Sports Medicine Hospital Qatar
© WADA - World Anti-Doping Program 6 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Dr. David Handelsman ANZAC Research Institute University of Sydney Department of Andrology, Concord Hospital Sydney Australia
Professor Vin Tangpricha Associate Professor Division of Endocrinology, Metabolism and Lipids, Department of Medicine Emory University School of Medicine and the Section of Endocrinology Atlanta VA Medical Center Atlanta, GA United States of America
Growth Hormone Deficiency (Adult / Childhood and Adolescent)
Professor Yves Le Bouc Endocrinologist Director at INSERM Faculty of Medicine Saint Antoine – University Paris VI Paris France
Dr. Tom Parkhill Endocrinologist Independent Consultant San Remo Area Italy
Infertility Polycystic Ovarian Syndrome
Dr. Margo Mountjoy, M.D., CCFP, FCFP, FACSM, Dip Sport Med FINA Bureau Sports Medicine Liaison IOC Medical Commission – Games Group McMaster University Medical School, Department of Family Medicine Rockwood, Ontario Canada
Professor Robert L. Reid Professor Obstetrics & Gynecology Chair, Division of Reproductive Endocrinology and Infertility Queen's University Kingston, Ontario Canada
© WADA - World Anti-Doping Program 7 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Professor Timothy Rowe Professor Obstetrics & Gynecology Head, Division of Reproductive Endocrinology and Infertility University of British Columbia Vancouver, British Columbia Canada
Professor Heather Shapiro Professor Obstetrics and Gynecology Reproductive Endocrinology and Infertility Mount Sinai Hospital Associate University of Toronto Toronto, Ontario Canada
Inflammatory Bowel Disease
Professor Dr. David Gerrard Associate Dean, University of Otago Medical School New Zealand
Dr. Martin Schlup Gastroenterologist Department of Medicine, University of Otago, Dunedin School of Medicine New Zealand
Intravenous Infusions
Professor Dr. David Gerrard Associate Dean, University of Otago Medical School New Zealand
Dr. Ola Rønsen Chief Medical Officer Corporate HSE Aker Solutions Holding Norway
Musculoskeletal Conditions
Professor Dr. David Gerrard Associate Dean, University of Otago Medical School New Zealand
© WADA - World Anti-Doping Program 8 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Dr. Chin Sim Teoh, MBBS (S’pore), MSS(SpMed)(Hons), GDAcu,GCertSpNutr, GDBA Director and Senior Consultant, Sports Medicine Centre Khoo Teck Puat Hospital Singapore
Narcolepsy-Cataplexy
Dr. Bertrand Carlander, M.D. Montpellier France
Dr. Susan White Chair, Australian Sports Drug Medical Advisory Committee Sports Physician, AOC Medical Commission Melbourne Australia
Neuropathic Pain
Mr. Matt Fedoruk Science Director, USADA Colorado USA
IPC Medical Committee (2014)
Dr. Matthias Strupler, M.D. Head of Sports Medicine, Swiss Paraplegic Center CMO Swiss Paralympic Committee IPC Medical Committee Nottwil Switzerland
Dr. Chin Sim Teoh, MBBS (S’pore), MSS (SpMed)(Hons), GDAcu, GCertSpNutr, GDBA Director and Senior Consultant, Sports Medicine Centre Khoo Teck Puat Hospital Singapore
Dr. Mark Ware, MBBS MRCP(UK) MSc. Associate Professor, Family Medicine and Anesthesia, McGill University Director of Clinical Research, Alan Edwards Pain Management Unit, McGill University Health Centre Co-Director of the Quebec Pain Research Network, and Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids Montreal, Quebec Canada
© WADA - World Anti-Doping Program 9 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Post Infectious Cough
Dr. Louis-Philippe Boulet Université Laval Sainte-Foy, Québec Canada
Professor Ken Fitch, M.D. School of Sport Science, Exercise and Health Faculty of Life Science, University of Western Australia Australia
Dr. Richard S. Irwin UMass Memorial Medical Center United States of America
Dr. Don McKenzie University of British Colombia Vancouver, British Columbia Canada
Dr. Margo Mountjoy, M.D., CCFP, FCFP, FACSM, Dip Sport Med FINA Bureau Sports Medicine Liaison IOC Medical Commission – Games Group McMaster University Medical School, Department of Family Medicine, Rockwood, Ontario Canada
Renal Transplantation
Professor Robert Walker Renal Physician Dunedin School of Medicine, University of Otago New Zealand
Sinusitis
Professor Louis-Phillipe Boulet Université Laval Sainte-Foy, Quebec Canada
© WADA - World Anti-Doping Program 10 Version 6.0 May 2015 TUE Physician Guidelines Medical Information to Support the Decisions of TUECs Major contributors
Professor Martin Desrosiers Clinical Professor, Division of Otolaryngology, Centre Hospitalier de l'Université de Montréal (CHUM), Department of Otolaryngology Montreal General Hospital, McGill University Montreal, Quebec Canada
Professor Ken Fitch, M.D. School of Sport Science, Exercise and Health Faculty of Life Science University of Western Australia Australia
Dr. Richard S. Irwin UMass Memorial Medical Center United States of America
Dr. Margo Mountjoy, M.D., CCFP, FCFP, FACSM, Dip Sport Med FINA Bureau Sports Medicine Liaison IOC Medical Commission – Games Group McMaster University Medical School, Department of Family Medicine, Rockwood, Ontario Canada
© WADA - World Anti-Doping Program 11 Version 6.0 May 2015